Firebrick Pharma (ASX:FRE) Long-Term Capital Lease Obligation : A$0.00 Mil (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Firebrick Pharma Long-Term Capital Lease Obligation?

Firebrick Pharma's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.00 Mil.

Firebrick Pharma Long-Term Capital Lease Obligation Historical Data

The historical data trend for Firebrick Pharma's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Firebrick Pharma Long-Term Capital Lease Obligation Chart

Firebrick Pharma Annual Data

Trend

Jun21

Jun22

Jun23

Long-Term Capital Lease Obligation

Firebrick Pharma Semi-Annual Data
	Jun22	Dec22	Jun23	Dec23
Long-Term Capital Lease Obligation	-	-	-	-

Firebrick Pharma (ASX:FRE) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Firebrick Pharma Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Firebrick Pharma's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Firebrick Pharma (ASX:FRE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Firebrick Pharma Ltd (ASX:FRE) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

440 Collins Street, Level 10, Melbourne, VIC, AUS, 3000

Website

https://www.firebrickpharma.com

Firebrick Pharma Ltd is an Australian pharmaceutical developer. It is engaged in the development and commercialization of Nasodine, a broad-spectrum anti-viral spray, designed to be an effective treatment and prevention of respiratory viral infections such as the common cold.

Firebrick Pharma (ASX:FRE) Headlines

No Headlines